Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 7
Submit an article Journal homepage
763
Views
2
CrossRef citations to date
0
Altmetric
Short Report

EV71 vaccination impact on the incidence of encephalitis in patients with hand, foot and mouth disease

Jian LiInfectious Diseases Department, Shandong University Qilu Children’s Hospital, Jinan, ChinaCorrespondence[email protected]
View further author information
,
Xiuzhi YinInfectious Diseases Department, Shandong University Qilu Children’s Hospital, Jinan, ChinaView further author information
,
Aiwei LinInfectious Diseases Department, Shandong University Qilu Children’s Hospital, Jinan, ChinaCorrespondence[email protected]
View further author information
,
Xiuzhen NieInfectious Diseases Department, Shandong University Qilu Children’s Hospital, Jinan, ChinaView further author information
,
Liyan LiuInfectious Diseases Department, Shandong University Qilu Children’s Hospital, Jinan, ChinaView further author information
,
Shihua LiuInfectious Diseases Department, Shandong University Qilu Children’s Hospital, Jinan, ChinaView further author information
,
Na LiInfectious Diseases Department, Shandong University Qilu Children’s Hospital, Jinan, ChinaView further author information
,
Ping WangInfectious Diseases Department, Shandong University Qilu Children’s Hospital, Jinan, ChinaView further author information
,
Shuangshuang SongInfectious Diseases Department, Shandong University Qilu Children’s Hospital, Jinan, ChinaView further author information
,
Shaoning WangInfectious Diseases Department, Shandong University Qilu Children’s Hospital, Jinan, ChinaView further author information
&
Daoyan XuInfectious Diseases Department, Shandong University Qilu Children’s Hospital, Jinan, ChinaView further author information
 show all
Pages 2097-2100 | Received 10 Aug 2020, Accepted 09 Nov 2020, Published online: 31 Jan 2021

References

  • Esposito S, Principi N. Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention. Eur J Clin Microbiol Infect Dis. 2018;37(3):391–98. doi:10.1007/s10096-018-3206-x.
  • Yi EJ, Shin YJ, Kim JH, Kim TG, Chang SY. Enterovirus 71 infection and vaccines. Clin Experim Vaccine Res. 2017;6:4–14.
  • Wang Y, Feng Z, Yang Y, Self S, Gao Y, Longini IM, Wakefield J, Zhang J, Wang L, Chen X, et al. Hand, foot, and mouth disease in China: patterns of spread and transmissibility. Epidemiology. 2011;22(6):781–92. doi:10.1097/EDE.0b013e318231d67a.
  • Zhang J, Sun J, Chang Z, Zhang W, Wang Z, Feng Z. Characterization of hand, foot, and mouth disease in China between 2008 and 2009. Biomed Environ Sci. 2011;24:214–21.
  • Lee TC, Guo HR, Su HJ, Yang YC, Chang HL, Chen KT. Diseases caused by enterovirus 71 infection. Pediatr Infect Dis J. 2009;28(10):904–10. doi:10.1097/INF.0b013e3181a41d63.
  • Chinese Centre for Disease Control and Prevention. Technical guideline on use of inactivated enterovirus 71 vaccine; 2016. [accessed 2019 Feb 17]. http://www.chinacdc.cn/zxdt/201606/W020160608725047001222.pdf
  • Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, Zhang Y, Li Y, Mao Q, Wang J, et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014;370(9):829–37. doi:10.1056/NEJMoa1303224.
  • Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, Tan X, Wang L, Mao Q, Wu J, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014;370(9):818–28. doi:10.1056/NEJMoa1304923.
  • Zhu FC, Meng FY, Li JX, Li XL, Mao QY, Tao H, Zhang Y-T, Yao X, Chu K, Chen Q-H, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381(9882):2024–232. doi:10.1016/S0140-6736(13)61049-1.
  • Guan X, Che Y, Wei S, Li S, Zhao Z, Tong Y, Wang L, Gong W, Zhang Y, Zhao Y, et al. Effectiveness and safety of an inactivated enterovirus 71 vaccine in children aged 6-71 months in a phase IV study [published online ahead of print, 2019 Nov 18]. Clin Infect Dis. 2019;ciz1114. doi:10.1093/cid/ciz1114.
  • Li JX, Song YF, Wang L, Zhang XF, Hu YS, Hu YM, Xia J-L, Li J, Zhu F-C. Two-year efficacy and immunogenicity of Sinovac Enterovirus 71 vaccine against hand, foot and mouth disease in children. Expert Rev Vaccines. 2016;15(1):129–37. doi:10.1586/14760584.2016.1096782.
  • Xu Q, Cao Q, Yang W, Liu X, Liu H, Tian X, Li J, Fang X, Jia N, Zeng G, et al. Interchangeability of two Enterovirus 71 inactivated vaccines in Chinese children: A phase IV, open-label, and randomized controlled trial. Vaccine. 2020;38(12):2671–77. doi:10.1016/j.vaccine.2020.02.013.
  • Guangwu W, Lijuan B. Epidemiological and etiological analysis of HFMD in border area of Chongzuo city from 2008 to 2017. Chin J Dis Control Prev. 2018;22:1028–31.
  • Xiaopu Z, Jun Z. Investigation on vaccination rate of EV71 vaccine in severe hand, foot and mouth in Qujing City and analysis of population inoculation intention. Health Way. 2017;14:248–49.
  • Wang Y, Meng F, Li J, Li G, Hu J, Cao J, Yu Q, Liang Q, Zhu F. Willingness of parents to vaccinate their 6-60-month-old children with EV71 vaccines: a cross-sectional study in rural areas of northern Jiangsu Province. Hum Vaccin Immunother. 2020;16(7):1579–85. doi:10.1080/21645515.2020.1737465.
  • Li Y, Zhou Y, Cheng Y, Wu P, Zhou C, Cui P, Song C, Liang L, Wang F, Qiu Q, et al. Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017-18: a test-negative case-control study. Lancet Child Adolesc Health. 2019;3(10):697–704. doi:10.1016/S2352-4642(19)30185-3.
  • Li Y, Chang Z, Wu P, Liao Q, Liu F, Zheng Y, Luo L, Zhou Y, Chen Q, Yu S, et al. Emerging enteroviruses causing hand, foot and mouth disease, China, 2010–2016. Emerg Infect Dis. 2018;24(10):1902–06. doi:10.3201/eid2410.171953.
  • Bian L, Wang Y, Yao X, Mao Q, Xu M, Liang Z. Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide. Expert Rev Anti Infect Ther. 2015;13(9):1061–71. doi:10.1586/14787210.2015.1058156.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.